I was selected to a highly competitive program as a research intern at Novartis in the summer of 2024. I worked under Dr. Giang Nguyen and Dr. Alan Ho on developing an efficient workflow for nanovial technology. This ultimately aims to cut down the time between laboratory research and patient treatment. In this project, we worked on creating a workflow that helps utilize this amazing Nanovial technology to isolate antigen-specific antibody producing B cells, which can help contribute to therapeutic development that can target specific pathogenic B cells. 

​